2024-06-08 02:42:56 ET
Summary
- Arcturus is a top pick in the biotech sector with a strong stock market performance.
- The company generates revenue from research and development partnerships, which helps conserve cash.
- The launch of the Kostaive vaccine and other programs are expected to drive revenue growth in the short and long term.
Arcturus ( ARCT ) is one of my top picks for the biotech sector as I have outlined in a previous piece . The stock market performance is a testament to the bullish rationale in this stock....
Read the full article on Seeking Alpha
For further details see:
Arcturus: A Hidden Gem In The Biotech Sector